2019
Molecular signatures of multiple myeloma progression through single cell RNA-Seq
Jang J, Li Y, Mitra A, Bi L, Abyzov A, van Wijnen A, Baughn L, Van Ness B, Rajkumar V, Kumar S, Jen J. Molecular signatures of multiple myeloma progression through single cell RNA-Seq. Blood Cancer Journal 2019, 9: 2. PMID: 30607001, PMCID: PMC6318319, DOI: 10.1038/s41408-018-0160-x.Peer-Reviewed Original ResearchConceptsMM patientsMultiple myelomaPoor overall survivalCD138-positive cellsBone marrow aspirateMultiple myeloma progressionSingle-cell RNA-seqMGUS patientsGene expression signaturesOverall survivalMM progressionDisease progressionMyeloma progressionPatient prognosisTreatment stratificationMarrow aspiratesPlasma cellsPositive cellsPatientsL4 groupGene signatureLow expressionExpression signaturesMolecular pathwaysProgression
2015
Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors
Mitra A, Mukherjee U, Harding T, Jang J, Stessman H, Li Y, Abyzov A, Jen J, Kumar S, Rajkumar V, Van Ness B. Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors. Leukemia 2015, 30: 1094-1102. PMID: 26710886, DOI: 10.1038/leu.2015.361.Peer-Reviewed Original ResearchConceptsSingle cellsIndividual cellsSignificant genetic diversitySingle-cell analysisGene expression profile signaturesSingle-cell levelGenetic diversityTranscriptome analysisDrug responseCellular responsesDrug sensitivityBulk populationInhibitor sensitivitySubclonal architectureProfiling studiesPCR analysisPrediction programsCell linesMyeloma cell linesTumor progressionCellsIntratumor heterogeneityProfile signaturesProteasome inhibitor sensitivitySubclonal level